Skip to main content

DaVita company profile

  • DVA · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$174.56+0.28%Close 13 Nov 2026 · Market value $11.03B

About DaVita

DaVita is a healthcare provider focused on kidney care, offering services across the continuum from slowing chronic kidney disease progression to supporting transplantation. Its largest line of business is U.S. dialysis, which provides outpatient hemodialysis, hospital inpatient dialysis, home-based hemodialysis and peritoneal dialysis, along with related laboratory services for patients with end stage kidney disease. Its ancillary services include integrated kidney care management for health plans and government programs, clinical research, a transplant software business and a venture group. The company also operates international dialysis centers in 14 countries outside the U.S. Its U.S. outpatient dialysis centers are located in 46 states and the District of Columbia, and it serves patients largely through government-based programs and commercial insurance plans.

A summary of the business section of the company's latest annual report, filed 11 Feb 2026.

Company facts

TickerDVA · NYSE
SectorHealthcare
IndustryHealth Care Services
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK927066
Latest annual report10-K, filed 11 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Javier J. RodriguezChief Executive Officer · Director845K · 1.3%Open-market sale, 16 Jun 2026
Joel AckermanCFO and Treasurer162K · < 1%Open-market sale, 7 May 2026
Kathleen A. WatersChief Legal & Pub. Affairs Off106K · < 1%Open-market sale, 15 Jun 2026
David P. MaughanChief Operating Officer, DKC47.1K · < 1%Shares withheld for tax, 22 Sep 2026
James O. HeartyChief Compliance Officer31.3K · < 1%Open-market sale, 15 May 2026
Pamela M. ArwayDirector26.7K · < 1%Grant or award, 15 Aug 2026
Phyllis R. YaleDirector14.3K · < 1%Grant or award, 15 Aug 2026
Barbara J. DesoerDirector13.8K · < 1%Grant or award, 15 Aug 2026
Gregory J. Moore, M.D., Ph.D.Director7.6K · < 1%Grant or award, 15 Aug 2026
Jason M. HollarDirector6.4K · < 1%Grant or award, 15 Aug 2026
Adam H. SchechterDirector5.4K · < 1%Grant or award, 15 Aug 2026
Wendy L. SchoppertDirector3.6K · < 1%Grant or award, 15 Aug 2026
Dennis W. PullinDirector2.4K · < 1%Grant or award, 15 Aug 2026
BERRY CHRISTOPHER MICHAELChief Accounting Officer—Grant or award, 15 Mar 2026
BERG CHARLESDirector—Grant or award, 15 May 2025

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

DVA in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.